Pimecrolimus cream 1% for mild to moderate facial atopic dermatitis in children

被引:0
|
作者
Zuberbier, Torsten [1 ]
Brautigam, Matthias [1 ]
机构
[1] Novartis Pharma GmbH, Nurnberg, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB50 / AB50
页数:1
相关论文
共 50 条
  • [31] Eczema herpeticum during treatment of atopic dermatitis with 1% pimecrolimus cream
    Segura, S
    Romero, D
    Carrera, C
    Iranzo, P
    Estrach, T
    ACTA DERMATO-VENEREOLOGICA, 2005, 85 (06) : 524 - 525
  • [32] Efficacy of Pimecrolimus 1% Cream in Various Clinical Forms of Atopic Dermatitis
    Ikizler, Ebru
    Karabacak, Ercan
    Karabudak, Oezlem
    Dogan, Bilal
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2010, 44 (02): : 83 - 87
  • [33] Systemic exposure of pimecrolimus cream 1% and tacrolimus ointment 0.1% in adult patients with moderate to severe atopic dermatitis
    Draelos, ZD
    Hanifin, J
    Chon, K
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P4 - P4
  • [34] A novel daily moisturizing cream for effective management of mild to moderate atopic dermatitis in infants and children
    Weber, T. M.
    Samarin, F.
    Babcock, M. J.
    Filbry, A.
    Arrowitz, C. E.
    Rippke, F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB73 - AB73
  • [35] Correction to: Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
    Sheridan M. Hoy
    American Journal of Clinical Dermatology, 2023, 24 : 495 - 495
  • [36] Pimecrolimus cream 1% provides long-term disease management in children with severe atopic dermatitis
    Kaufmann, R
    Goodfield, M
    Kapp, A
    Gourmala, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2002, 119 (01) : 350 - 350
  • [37] A 5-year randomized study to investigate the safety of pimecrolimus cream 1% in the treatment of mild-to-moderate atopic dermatitis in infants: Clinical safety
    Bishop, Michael
    Vukovic-Wysocki, Ivana
    Qaqundah, Paul
    Poulin, Yves
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB56 - AB56
  • [38] Randomized vehicle-controlled trial of pimecrolimus cream 1% in adult patients with mild to moderate head and neck atopic dermatitis intolerant of, or dependent on TCS
    Weise-Riccardi, S.
    Calvieri, S.
    Ortonne, J.
    Murrell, D. F.
    Ho, V. C.
    Emady-Azar, S.
    Paul, C. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 46 - 46
  • [39] A 5-year randomized study to investigate the safety of pimecrolimus cream 1% in the treatment of mild-to-moderate atopic dermatitis in infants: Immunologic parameters
    Poulin, Yves
    Kaoukhov, Alexandre
    Johnson, Anthony
    Bishop, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB58 - AB58
  • [40] Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children
    Wahn, U
    Bos, JD
    Goodfield, M
    Caputo, R
    Papp, K
    Manjra, A
    Dobozy, A
    Paul, C
    Molloy, S
    Hultsch, T
    Graeber, M
    Cherill, R
    de Prost, Y
    PEDIATRICS, 2002, 110 (01) : e2